ScholarIQanswers from OpenAlex & ORCID
Jean‐Jacques Grob
ResearcherPublications, citations & collaboration network
Jean‐Jacques Grob is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jean‐Jacques Grob have?
ScholarIQindexed works
Jean‐Jacques Grob has 1,007 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jean‐Jacques Grob have?
ScholarIQcitation count
Jean‐Jacques Grob has 81,657 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jean‐Jacques Grob?
ScholarIQh-index
Jean‐Jacques Grob has an h-index of 106 in OpenAlex.
What is the i10-index of Jean‐Jacques Grob?
ScholarIQi10-index
Jean‐Jacques Grob has an i10-index of 384 in OpenAlex.
What is the ORCID of Jean‐Jacques Grob?
ScholarIQorcid
The ORCID for Jean‐Jacques Grob is on the source record.
What is the OpenAlex record for Jean‐Jacques Grob?
ScholarIQopenalex
The OpenAlex for Jean‐Jacques Grob is on the source record.
What are the most-cited papers on Jean‐Jacques Grob?
ScholarIQmost cited works
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor, F. Stephen Hodi, Ralf Gutzmer, Bart Neyns, Christoph Höeller, Nikhil I. Khushalani, Wilson H. Miller, Christopher D. Lao, Gerald P. Linette, L. Thomas, Paul Lorigan, Kenneth F. Grossmann, Jessica C. Hassel, Michele Maio, Mario Sznol, Paolo A. Ascierto, Peter Mohr, Bartosz Chmielowski, Alan H. Bryce, Inge Marie Svane, Jean‐Jacques Grob, Angela M. Krackhardt, Christine E. Horak, Alexandre Lambert, Arvin Yang, James Larkin
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Georgina V. Long, Reinhard Dummer, Omid Hamid, Thomas F. Gajewski, Christian Caglevic, Stéphane Dalle, Ana Arance, Matteo S. Carlino, Jean‐Jacques Grob, Tae Min Kim, Lev Demidov, Caroline Robert, James Larkin, James R. Anderson, Janet Maleski, Mark M. Jones, Scott J. Diede, Tara C. Mitchell
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
Claus Garbe, Ketty Peris, Axel Hauschild, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Jean‐Jacques Grob, Josep Malvehy, Julia Newton‐Bishop, Alexander Stratigos, Hubert Pehamberger, Alexander M.M. Eggermont
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Célèste Lebbé, Josep Malvehy, V. del Mármol, Hubert Pehamberger, Ketty Peris, Jürgen C. Becker, Iris Zalaudek, Philippe Saïag, Mark R. Middleton, Lars Bastholt, Alessandro Testori, Jean‐Jacques Grob